R&D
RNA-Therapeutics Firm Rznomics Joins Lilly’s San Diego Incubator
The Korean biotech will tap Eli Lilly’s labs, scientists and infrastructure to speed its RNA-based gene therapies — an incubator arrangement, not an acquisition.